The parabrachial (PBN) and Kölliker-Fuse (KF) are nuclei that are located in the dorsal lateral part of the pons. 1 The KF nucleus refers to a population of largely glutamatergic neurons 2 that receive axonal termination from the retrotrapezoid nucleus and the caudal portion of the nucleus tractus solitarius, the area in the brain stem which involves in chemoreflex and baroreflex suggesting a possible role in the chemoreflex and baroreflex control. [3] [4] [5] The C-Fos-immunoreactive study showed the intense activation of labeled KF neurons after hypoxia and hypercapnia. [6] [7] [8] [9] The KF also has extensive interconnections with brain areas involved in cardiovascular response. 10 Electrical or chemical stimulations of loci within the lateral parabrachial nuclei and KF increased arterial pressure and produced mild tachycardia. 11 The KF region contributes to respiratory chemoreflex but there was no study investigating the cardiovascular chemoreflex by hypoxic-hypoxia methods.
peak tachycardia and hypotension after 8% O2 breathing were calculated and compared with those of the preintervention (injecting of cocl 2 ). The baroreflex activity was evaluated by measurement of the increase of MAP, maximum of decrease in heart rate, and the baroreflex gain (the ratio of the maximum ΔHR to t h e maximum ΔMAP). The values were compared before, and 5, 15, and 40 minutes after treatments using repeated-measures ANOVA. Moreover, the values were compared with the preinjection values using a paired t-test.
Experimental groups
The first group: Activation of arterial baroreceptors was performed by intravenous injections of Phe before (control) and 5, 15, and 40 minutes after bilateral microinjection saline (100 nL/each side, n=8 rats) into the KF.
The second group: Activation of arterial baroreceptors was performed before (control) and 5, 15, and 40 minutes after bilateral microinjection cobalt chloride (CoCl 2 , 5 mM, 100 nL/side, Sigma, USA, n = 7 rats) into the KF. 15 The third group: Arterial chemoreceptors were activated with the inhalation of 8% O2 and 92% N2 before (control) and 5, 15, and 40 minutes after bilateral microinjection saline (100 nL/each side, n = 6 rats) into the KF.
The fourth group: Activation of arterial chemoreceptors was evoked before (control) and 5, 15, and 40 minutes after bilateral microinjection cobalt chloride (CoCl 2 , 5 mM, 100 nL/side, n = 7 rats) into the KF.
Histology
At the end of the experiments, rats were anesthetized with a high dose of urethane. The chest was surgically opened, the descending aorta occluded, the right atrium cut off and the brain perfused with saline followed by 100 mL of formalin (10%) through the left ventricle. Brains were postfixed for at least 24 and 50 μm sections of the brain at the level of the pons were cut using a cryostat (Microm HM 525, Germany). Sections were mounted on glass slides and stained with cresyl violet (1%). All stimulation sites were mapped according to a rat brain atlas, 13 under the light microscope.
Results

Effects of saline on the cardiovascular baroreflex and gain
For the control group, baroreflex responses were evoked by intravenous injection of Phe used to activate arterial baroreceptors before and 5, 15, and 40 minutes after bilateral injection of saline (100 nL/side) into the KF of spontaneously breathing rats (n = 8 rats).
Microinjection of saline did not significantly affect the baseline values MAP, HR (MAP= 100.6±5.8 vs. 100.4±5.8 mm Hg and HR=317.4±6.7 vs. 325.5 ±9.2 bpm, n = 8 rats; paired t-test, P > 0.05, Fig. 1 ). Microinjection of saline also had not a significant effect on the pressor or bradycardic 12-hour light/dark cycle with a room temperature of ~ 25°C. Surgical procedures were similar to our previous experiments. General anesthesia was induced with urethane, with an initial dose of 1.4 g/kg; i.p. Surgical anesthesia was affirmed if no withdrawal reflex of a hind limb was observed. The adequacy of anesthesia was examined regularly and a supplementary dose (10% of the initial dose i.p) was administered as needed.
Rectal temperature was monitored and maintained at 37±1 by the heating pad temperature controller.
The trachea was cannulated to facilitate ventilation. In some groups, the animals were mechanically ventilated using a small rodent ventilator (Harvard Apparatus; model 683). A polyethylene catheter (PE-50, AD instrument) filled with heparinized saline was inserted into the femoral artery and vein for recording the arterial pressure and activating chemoreflex, respectively. To record arterial pressure and heart rate, the femoral artery cannula was connected to an ML T844 pressure transducer coupled to a pre-amplifier (FE221 Bridge amplifier, AD instruments, AU) connected to a power lab 4/35 data acquisition system (model PL3504 AD instruments, AU). For drug microinjection into the KF, rats were placed on a stereotaxic frame (Stoleting, USA). The skull was drilled above the KF at coordinates of 2.45-2.55 mm lateral from midline, 8.6-9.2 mm caudal to bregma and 7.4-8.2 mm below to the surface of bregma according to a rat brain atlas. 13
Drug microinjections and baroreflex and chemoreflex activation
Glass micropipettes (Stoleting, USA) were pulled by a micropipette puller (Narishigi, Japan). A single barrel micropipette was inserted into each KF for bilateral microinjection. Saline and cobalt chloride (100 nL/side) were microinjected into the KF using a micropipette with a tip diameter of 35-45 µm. The volume of Injection was monitored by direct observation of fluid meniscus in the micropipettes that allowed a 2-nL resolution (U.W.O, Canada). Cobalt chloride was dissolved in saline. Carotid chemoreceptor stimulation was done by ventilating the rats with 8% O2 in 92% N2 for 1-2 minutes using ventilator "hypoxic-hypoxia methods". 14 Baroreceptor activation was done with i.v. administration of phenylephrine (Phe, 20 µg /kg/0.05-0.1 mL).
Data analysis
The results are expressed as mean ± standard error of the mean (SEM). All data were tested for normality (Shapiro-Wilk test). Since all data were normal, parametric tests were used. Mean arterial pressure (MAP) and heart rate (HR) were compared with the pre-injection values using paired t-test, and different interval values were compared using repeated-measures ANOVA. A P<0.05 was considered to indicate statistical significance. To evaluate the cardiovascular chemoreflex, the mean of the responses of the cardiovascular baroreflex and gain (pressor before = 59.54±5.87 mm Hg, after 5 minutes: 61.54±5.95 mmHg; bradycardia: before = -88±17.78 bpm, after 5 minutes: -84.18 ± 18.19 bpm; gain: before = -1.55±0.34 after -1.38±0.27; paired t-test between before and 5 minutes after: P > 0.05, repeated measures ANOVA: P > 0.05; Fig. 1 ) confirming that the changes seen in the other groups are not due to the injection of the vehicle.
Cardiovascular baroreflex and gain to microinjection of cobalt chloride into the KF
To find if the KF neurons play a role in the cardiovascular baroreflex, the KF was reversibly blocked by bilateral cobalt chloride (CoCl 2 , 5mM, 100 nL/side,). Microinjection of CoCl 2 into the KF did not significantly affect the baseline values of MAP and HR (MAP= 82.71 ± 4.45 vs. 83.25 ± 4.43 mm Hg and HR = 351.71 ± 14.71 vs. 351.28 ± 14.30 bpm, paired t-test, P > 0.05, n = 7 rats). Systemic administration of Phe before and after bilateral injection of CoCl 2 had no significant effect on the pressor, bradycardic and gain responses of the cardiovascular baroreflex (pressor before = 76.28±2.38 mm Hg, after 5 minutes: 76.42 ± 2.47 mm Hg; bradycardia: before = -126.85±4.93 bpm, after 5 minutes: -126 ± 5.52 bpm; gain: before = -1.67±0.07 after -1.65 ± 0.08; repeated measures ANOVA: P > 0.05; paired t-test between before and 5 minutes after: P > 0.05, Figs.  2 and 3 ).
Effects of saline on the cardiovascular chemoreflex
Hypoxia was induced by artificial respiration via a ventilator with 8% O2 in 92% N2 for 1-2 minutes to stimulate arterial chemoreceptors before and 5, 15, and 40 minutes after bilateral injection of saline (100 nL/side) into the KF (n = 6 rats). Hypoxia elicited a fall in arterial pressure with peripheral vasodilatation and tachycardia. Microinjection of saline did not significantly affect baseline values of MAP, HR (MAP = 93.8±5.88 vs. 93.4±5.52 mm Hg and HR=366±13.41 vs 367.2 ±13.44 bpm, n = 6 rats; paired t-test, P > 0.05, Fig. 4 ). Microinjection of saline also had no significant effect on the depressor or tachycardic responses (depressor before = -32.8±3.30 mm Hg, after 5 minutes: -31.8±3.29 mm Hg; tachycardia: before = 23.6±1.28 bpm, after 5 minutes: -22.8 ±2.47 bpm; repeated measures ANOVA: P > 0.05; paired t-test between before and 5 minutes after: P > 0.05, Fig. 4 ).
Effect of microinjection of cobalt chloride into the KF on the cardiovascular chemoreflex
Microinjection of CoCl 2 (5mM, 100 nL/side, n = 7 rats) into the KF did not significantly affect the baseline values of MAP and HR (MAP = 103.28±5.41 vs. 103.28±5.37 mm 
Histology
A photomicrograph with two injection sites is displayed in Fig. 7 . The diagrammatic representation base on rat brain atlas is shown in Fig. 8 . Data of the injection sites outside the KF were not included in the analysis.
Discussion
The peripheral chemoreflex responses are an important mechanism during the hypoxic state in a patient with sleep apnea, hypertension 16, 17 and sudden infant death syndrome. 18 The present study provides the cardiovascular evidence indicating the involvement of the KF nucleus in the cardiovascular chemoreflex evoked by systemic inhalation of 8% O2 and 92% of N2 in artificially ventilated urethane anesthetized rats. Whereas the KF had no effect on baroreflex evoked by systemic administration of phenylephrine. In this study, hypoxia was used to stimulate arterial chemoreceptors, Hypoxia elicited hypotension due to peripheral vasodilatation and the reflex of tachycardia. This response was similar to that reported by other investigators using N2 to elicit chemoreflex responses in pentobarbitone -anesthetized rats. 12 Lack of response to saline microinjection demonstrated that the baroreceptors and chemoreceptors cardiovascular responses were not owing to mechanical distortion or volume injection ( Figs.  1 and 4) .
To find the possible involvement of the KF in the cardiovascular chemoreflex, cobalt chloride, a reversible synaptic blocker was used. Bilateral microinjections of CoCl 2 into the KF markedly attenuated the component of tachycardic response with no change in depressor response which is due to peripheral vasodilatation ( Figs. 5 and 6) , confirming that the KF is an important site for generating cardiovascular chemoreflex. Anatomical and physiological pieces of evidence have already demonstrated that the KF receives peripheral chemoreceptor signals. [6] [7] [8] [9] The recovery time of CoCl 2 was ranged from 20-40 minutes (Figs. 2 and 5) and complete recovery from the effects occurred within 60 minutes. The effect of hypoxia to generate chemoreflex responses was extremely reproducible and highly significant as indicated in the figures.
Baroreceptor activations were performed by systemic administration of Phe before and after reversible synaptic blocker, which had no significant effect on the pressor and bradycardic reflex and gain (Fig. 3) confirming that the KF does not receive arterial pressure information from baroreceptors and has no role in baroreflex. A possible criticism of this study is the use of hypoxia (8% O2), and the generation of peripheral hypotension may activate the baroreflex due to the direct effects of decreased arterial pressure on the baroreceptors. In contrast, during baroreflex activation, sympathoexcitation occurs, which stimulates primarily central chemoreceptors. The baroreceptor-chemoreceptor interaction was previously described in animals, [19] [20] [21] [22] and humans. 23 In the clinic, the baroreflex impairment known to occur in hypertension may result in a loss of the inhibitory tonic or inhibitory permeation of baroreceptors on the excitatory effect of chemoreceptors during hypoxia. Activation of the baroreflexes has an inhibitory influence on chemoreflex BioImpacts, 2020, 10(1), 55-61 60 gain as we see in sleep apnea. 24 Activation of the baroreflex can inhibit both ventilatory and autonomic responses to chemoreflex activation. 23, 25, 26 Conditions that are associated with impaired baroreflex gains, such as hypertension and heart failure, 23, 25 would also be accompanied by exaggerated chemoreflex responses.
Conclusion
In conclusion, these data demonstrate that the KF has no role in baroreflex but plays an essential role in cardiovascular chemoreflex.
